These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20184575)

  • 61. Insulin resistance and aging: a cause or a protective response?
    Barzilai N; Ferrucci L
    J Gerontol A Biol Sci Med Sci; 2012 Dec; 67(12):1329-31. PubMed ID: 22859390
    [No Abstract]   [Full Text] [Related]  

  • 62. [Total care for patients with metabolic syndrome].
    Takata N; Katayama S
    Nihon Rinsho; 2004 Jun; 62(6):1164-9. PubMed ID: 15206158
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [A rat model of metabolic syndrome].
    Ikeda K; Yasui N; Yamamoto J; Nara Y; Yamori Y
    Nihon Rinsho; 2006 Dec; 64 Suppl 9():339-42. PubMed ID: 17458243
    [No Abstract]   [Full Text] [Related]  

  • 64. [Urinary calculi. 2: Metabolic defects, nutrition errors and metaphylaxis].
    Hesse A
    Urologe A; 2002 Nov; 41(6):616-28; quiz 628-9. PubMed ID: 12524951
    [No Abstract]   [Full Text] [Related]  

  • 65. The metabolic syndrome debate. What it means to you when experts disagree about a set of risk factors.
    Heart Advis; 2006 May; 9(5):4-5. PubMed ID: 16718919
    [No Abstract]   [Full Text] [Related]  

  • 66. Rosiglitazone cools down inflammation in the metabolic syndrome.
    Esposito K; Ciotola M; Merante D; Giugliano D
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1413-4. PubMed ID: 16709957
    [No Abstract]   [Full Text] [Related]  

  • 67. Hirsutism region and the likelihood of metabolic syndrome: is there a link?
    Minooee S; Ramezani Tehrani F; Azizi F
    Endocrine; 2016 Aug; 53(2):607-9. PubMed ID: 26668059
    [No Abstract]   [Full Text] [Related]  

  • 68. [Metabolic syndrome and carcinogenesis].
    Hippo Y; Nakagama H
    Nihon Rinsho; 2011 Jan; 69 Suppl 1():438-43. PubMed ID: 21766638
    [No Abstract]   [Full Text] [Related]  

  • 69. Demographics of stone disease--are they changing?
    Monga M
    J Urol; 2013 Jan; 189(1):16. PubMed ID: 23085053
    [No Abstract]   [Full Text] [Related]  

  • 70. Causal effects of circulating lipids and lipid-lowering drugs on the risk of urinary stones: a Mendelian randomization study.
    Tan Z; Hong J; Sun A; Ding M; Shen J
    Front Endocrinol (Lausanne); 2023; 14():1301163. PubMed ID: 38107516
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Association between hyperlipidemia and calcium oxalate lower urinary tract uroliths in dogs.
    Paulin MV; Dunn M; Vachon C; Beauchamp G; Conversy B
    J Vet Intern Med; 2022 Jan; 36(1):146-155. PubMed ID: 34854133
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Uric acid lowering improves insulin sensitivity and lowers blood pressure: a meta-analysis of randomized parallel-controlled clinical trials.
    Zong Q; Ma G; Wang T
    Afr Health Sci; 2021 Mar; 21(1):82-95. PubMed ID: 34394285
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Macrophage Function in Calcium Oxalate Kidney Stone Formation: A Systematic Review of Literature.
    Taguchi K; Okada A; Unno R; Hamamoto S; Yasui T
    Front Immunol; 2021; 12():673690. PubMed ID: 34108970
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Allopurinol ameliorates high fructose diet induced hepatic steatosis in diabetic rats through modulation of lipid metabolism, inflammation, and ER stress pathway.
    Cho IJ; Oh DH; Yoo J; Hwang YC; Ahn KJ; Chung HY; Jeong SW; Moon JY; Lee SH; Lim SJ; Jeong IK
    Sci Rep; 2021 May; 11(1):9894. PubMed ID: 33972568
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Association of nephrolithiasis with the risk of cardiovascular diseases: a longitudinal follow-up study using a national health screening cohort.
    Kim SY; Bang WJ; Min C; Choi HG
    BMJ Open; 2020 Nov; 10(11):e040034. PubMed ID: 33191264
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Predictive value of preoperative inflammatory response biomarkers for metabolic syndrome and post-PCNL systemic inflammatory response syndrome in patients with nephrolithiasis.
    Tang K; Liu H; Jiang K; Ye T; Yan L; Liu P; Xia D; Chen Z; Xu H; Ye Z
    Oncotarget; 2017 Oct; 8(49):85612-85627. PubMed ID: 29156745
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Marked increase in urinary excretion of apolipoproteins in children with nephrolithiasis associated with hypercalciuria.
    Kovacevic L; Lu H; Caruso JA; Govil-Dalela T; Thomas R; Lakshmanan Y
    Pediatr Nephrol; 2017 Jun; 32(6):1029-1033. PubMed ID: 28188435
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Metabolic syndrome and nephrolithiasis.
    Ramaswamy K; Shah O
    Transl Androl Urol; 2014 Sep; 3(3):285-95. PubMed ID: 26816779
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Diabetes mellitus and the risk of urolithiasis: a meta-analysis of observational studies.
    Liu LH; Kang R; He J; Zhao SK; Li FT; Zhao ZG
    Urolithiasis; 2015 Aug; 43(4):293-301. PubMed ID: 25894627
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Correlation of the body mass index and calcium nephrolithiasis in adult population.
    Milicevic S; Bijelic R; Krivokuca V; Bojic M; Popovic-Pejicic S; Bojanic N
    Med Arch; 2013 Dec; 67(6):423-7. PubMed ID: 25568513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.